Cancer Home > Crizotanib
Were you looking for information about Crizotinib? Crizotanib is a common misspelling of crizotinib.
By blocking the activity of certain proteins in the body that help cancer cells grow, crizotinib (Xalkori®) can help slow down the progression of advanced non-small cell lung cancer in adults. Specifically, this prescription drug is approved for use in people who have a defect in a gene known as the anaplastic lymphoma kinase (ALK) gene.
Crizotinib comes as a capsule and is taken twice daily. Although some people may not have any problems with this medicine, side effects are possible and can include nausea, vomiting, and diarrhea.
(For more information on this medicine, click Crizotinib. This full-length article offers a complete overview of this chemotherapy drug, including how it works, safety precautions, and general dosing guidelines. You can also click any of the links in the box to the right for specific information.)